0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hydrophilic Neurovascular Guidewire Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-2C17337
Home | Market Reports | Health| Medical Devices & Equipment
Global Hydrophilic Neurovascular Guidewire Market Research Report 2024
BUY CHAPTERS

Global Hydrophilic Neurovascular Guidewire Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-2C17337
Report
November 2025
Pages:210
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hydrophilic Neurovascular Guidewire Market

The global Hydrophilic Neurovascular Guidewire market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Neurovascular Intervention Guidewires are thin, flexible wire used in neurointerventional procedures to access and navigate through blood vessels in the brain and spinal cord. The wire is inserted through a catheter and carefully guided to the target site, serving as a pathway for placing other devices such as stents or coils.
From a downstream perspective, Residential accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Hydrophilic Neurovascular Guidewire leading manufacturers including Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation, B. Braun Melsungen, Teleflex, etc., dominate supply; the top five capture approximately % of global revenue, with Terumo Medical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Hydrophilic Neurovascular Guidewire market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Hydrophilic Neurovascular Guidewire Market Report

Report Metric Details
Report Name Hydrophilic Neurovascular Guidewire Market
Segment by Type
  • Large
  • Small & Medium
Segment by Application
  • Residential
  • Commercial
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation, B. Braun Melsungen, Teleflex, TE Con​​nectivity, Johnson & Johnson, Smiths Group, Asahi Intecc, Cordis Corporation, Cook Medical, Lepu Meidcal, Scientia Vascular, FMD Co., Ltd., Sino Medical Sciences Technology Inc., MicroPort NeuroTech, Shanghai HeartCare Medical Technology Corporation Limited, Peijia Medical, Zhejiang Medical Devices Co., Ltd. Owned By Year, Shanghai Yingtai Medical Equipment, Beijing Taijieweiye Technology, Shunmei MEDICAL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Hydrophilic Neurovascular Guidewire study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Hydrophilic Neurovascular Guidewire Market report?

Ans: The main players in the Hydrophilic Neurovascular Guidewire Market are Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation, B. Braun Melsungen, Teleflex, TE Con​​nectivity, Johnson & Johnson, Smiths Group, Asahi Intecc, Cordis Corporation, Cook Medical, Lepu Meidcal, Scientia Vascular, FMD Co., Ltd., Sino Medical Sciences Technology Inc., MicroPort NeuroTech, Shanghai HeartCare Medical Technology Corporation Limited, Peijia Medical, Zhejiang Medical Devices Co., Ltd. Owned By Year, Shanghai Yingtai Medical Equipment, Beijing Taijieweiye Technology, Shunmei MEDICAL

What are the Application segmentation covered in the Hydrophilic Neurovascular Guidewire Market report?

Ans: The Applications covered in the Hydrophilic Neurovascular Guidewire Market report are Residential, Commercial, Other

What are the Type segmentation covered in the Hydrophilic Neurovascular Guidewire Market report?

Ans: The Types covered in the Hydrophilic Neurovascular Guidewire Market report are Large, Small & Medium

1 Study Coverage
1.1 Introduction to Hydrophilic Neurovascular Guidewire: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Hydrophilic Neurovascular Guidewire Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Large
1.2.3 Small & Medium
1.3 Market Segmentation by Application
1.3.1 Global Hydrophilic Neurovascular Guidewire Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Residential
1.3.3 Commercial
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hydrophilic Neurovascular Guidewire Revenue Estimates and Forecasts 2020-2031
2.2 Global Hydrophilic Neurovascular Guidewire Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Hydrophilic Neurovascular Guidewire Sales Estimates and Forecasts 2020-2031
2.4 Global Hydrophilic Neurovascular Guidewire Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Hydrophilic Neurovascular Guidewire Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Hydrophilic Neurovascular Guidewire Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Large Market Size by Manufacturers
3.5.2 Small & Medium Market Size by Manufacturers
3.6 Global Hydrophilic Neurovascular Guidewire Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Hydrophilic Neurovascular Guidewire Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Hydrophilic Neurovascular Guidewire Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Hydrophilic Neurovascular Guidewire Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Hydrophilic Neurovascular Guidewire Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Hydrophilic Neurovascular Guidewire Sales and Revenue by Type (2020-2031)
6.4 North America Hydrophilic Neurovascular Guidewire Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Hydrophilic Neurovascular Guidewire Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Hydrophilic Neurovascular Guidewire Sales and Revenue by Type (2020-2031)
7.4 Europe Hydrophilic Neurovascular Guidewire Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Hydrophilic Neurovascular Guidewire Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Hydrophilic Neurovascular Guidewire Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Hydrophilic Neurovascular Guidewire Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Hydrophilic Neurovascular Guidewire Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Hydrophilic Neurovascular Guidewire Sales and Revenue by Type (2020-2031)
9.4 Central and South America Hydrophilic Neurovascular Guidewire Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Hydrophilic Neurovascular Guidewire Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Hydrophilic Neurovascular Guidewire Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Hydrophilic Neurovascular Guidewire Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Hydrophilic Neurovascular Guidewire Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Terumo Medical
11.1.1 Terumo Medical Corporation Information
11.1.2 Terumo Medical Business Overview
11.1.3 Terumo Medical Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.1.4 Terumo Medical Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Terumo Medical Hydrophilic Neurovascular Guidewire Sales by Product in 2024
11.1.6 Terumo Medical Hydrophilic Neurovascular Guidewire Sales by Application in 2024
11.1.7 Terumo Medical Hydrophilic Neurovascular Guidewire Sales by Geographic Area in 2024
11.1.8 Terumo Medical Hydrophilic Neurovascular Guidewire SWOT Analysis
11.1.9 Terumo Medical Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.2.4 Medtronic Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Hydrophilic Neurovascular Guidewire Sales by Product in 2024
11.2.6 Medtronic Hydrophilic Neurovascular Guidewire Sales by Application in 2024
11.2.7 Medtronic Hydrophilic Neurovascular Guidewire Sales by Geographic Area in 2024
11.2.8 Medtronic Hydrophilic Neurovascular Guidewire SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Corporation Information
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.3.4 Abbott Laboratories Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Abbott Laboratories Hydrophilic Neurovascular Guidewire Sales by Product in 2024
11.3.6 Abbott Laboratories Hydrophilic Neurovascular Guidewire Sales by Application in 2024
11.3.7 Abbott Laboratories Hydrophilic Neurovascular Guidewire Sales by Geographic Area in 2024
11.3.8 Abbott Laboratories Hydrophilic Neurovascular Guidewire SWOT Analysis
11.3.9 Abbott Laboratories Recent Developments
11.4 Stryker
11.4.1 Stryker Corporation Information
11.4.2 Stryker Business Overview
11.4.3 Stryker Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.4.4 Stryker Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Stryker Hydrophilic Neurovascular Guidewire Sales by Product in 2024
11.4.6 Stryker Hydrophilic Neurovascular Guidewire Sales by Application in 2024
11.4.7 Stryker Hydrophilic Neurovascular Guidewire Sales by Geographic Area in 2024
11.4.8 Stryker Hydrophilic Neurovascular Guidewire SWOT Analysis
11.4.9 Stryker Recent Developments
11.5 Penumbra
11.5.1 Penumbra Corporation Information
11.5.2 Penumbra Business Overview
11.5.3 Penumbra Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.5.4 Penumbra Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Penumbra Hydrophilic Neurovascular Guidewire Sales by Product in 2024
11.5.6 Penumbra Hydrophilic Neurovascular Guidewire Sales by Application in 2024
11.5.7 Penumbra Hydrophilic Neurovascular Guidewire Sales by Geographic Area in 2024
11.5.8 Penumbra Hydrophilic Neurovascular Guidewire SWOT Analysis
11.5.9 Penumbra Recent Developments
11.6 Merit Medical Systems
11.6.1 Merit Medical Systems Corporation Information
11.6.2 Merit Medical Systems Business Overview
11.6.3 Merit Medical Systems Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.6.4 Merit Medical Systems Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Merit Medical Systems Recent Developments
11.7 Boston Scientific
11.7.1 Boston Scientific Corporation Information
11.7.2 Boston Scientific Business Overview
11.7.3 Boston Scientific Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.7.4 Boston Scientific Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Boston Scientific Recent Developments
11.8 Integer Holdings Corporation
11.8.1 Integer Holdings Corporation Corporation Information
11.8.2 Integer Holdings Corporation Business Overview
11.8.3 Integer Holdings Corporation Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.8.4 Integer Holdings Corporation Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Integer Holdings Corporation Recent Developments
11.9 B. Braun Melsungen
11.9.1 B. Braun Melsungen Corporation Information
11.9.2 B. Braun Melsungen Business Overview
11.9.3 B. Braun Melsungen Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.9.4 B. Braun Melsungen Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 B. Braun Melsungen Recent Developments
11.10 Teleflex
11.10.1 Teleflex Corporation Information
11.10.2 Teleflex Business Overview
11.10.3 Teleflex Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.10.4 Teleflex Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Teleflex Recent Developments
11.11 TE Con​​nectivity
11.11.1 TE Con​​nectivity Corporation Information
11.11.2 TE Con​​nectivity Business Overview
11.11.3 TE Con​​nectivity Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.11.4 TE Con​​nectivity Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 TE Con​​nectivity Recent Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Corporation Information
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.12.4 Johnson & Johnson Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Johnson & Johnson Recent Developments
11.13 Smiths Group
11.13.1 Smiths Group Corporation Information
11.13.2 Smiths Group Business Overview
11.13.3 Smiths Group Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.13.4 Smiths Group Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Smiths Group Recent Developments
11.14 Asahi Intecc
11.14.1 Asahi Intecc Corporation Information
11.14.2 Asahi Intecc Business Overview
11.14.3 Asahi Intecc Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.14.4 Asahi Intecc Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Asahi Intecc Recent Developments
11.15 Cordis Corporation
11.15.1 Cordis Corporation Corporation Information
11.15.2 Cordis Corporation Business Overview
11.15.3 Cordis Corporation Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.15.4 Cordis Corporation Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Cordis Corporation Recent Developments
11.16 Cook Medical
11.16.1 Cook Medical Corporation Information
11.16.2 Cook Medical Business Overview
11.16.3 Cook Medical Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.16.4 Cook Medical Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Cook Medical Recent Developments
11.17 Lepu Meidcal
11.17.1 Lepu Meidcal Corporation Information
11.17.2 Lepu Meidcal Business Overview
11.17.3 Lepu Meidcal Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.17.4 Lepu Meidcal Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Lepu Meidcal Recent Developments
11.18 Scientia Vascular
11.18.1 Scientia Vascular Corporation Information
11.18.2 Scientia Vascular Business Overview
11.18.3 Scientia Vascular Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.18.4 Scientia Vascular Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Scientia Vascular Recent Developments
11.19 FMD Co., Ltd.
11.19.1 FMD Co., Ltd. Corporation Information
11.19.2 FMD Co., Ltd. Business Overview
11.19.3 FMD Co., Ltd. Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.19.4 FMD Co., Ltd. Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 FMD Co., Ltd. Recent Developments
11.20 Sino Medical Sciences Technology Inc.
11.20.1 Sino Medical Sciences Technology Inc. Corporation Information
11.20.2 Sino Medical Sciences Technology Inc. Business Overview
11.20.3 Sino Medical Sciences Technology Inc. Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.20.4 Sino Medical Sciences Technology Inc. Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Sino Medical Sciences Technology Inc. Recent Developments
11.21 MicroPort NeuroTech
11.21.1 MicroPort NeuroTech Corporation Information
11.21.2 MicroPort NeuroTech Business Overview
11.21.3 MicroPort NeuroTech Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.21.4 MicroPort NeuroTech Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 MicroPort NeuroTech Recent Developments
11.22 Shanghai HeartCare Medical Technology Corporation Limited
11.22.1 Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
11.22.2 Shanghai HeartCare Medical Technology Corporation Limited Business Overview
11.22.3 Shanghai HeartCare Medical Technology Corporation Limited Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.22.4 Shanghai HeartCare Medical Technology Corporation Limited Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
11.23 Peijia Medical
11.23.1 Peijia Medical Corporation Information
11.23.2 Peijia Medical Business Overview
11.23.3 Peijia Medical Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.23.4 Peijia Medical Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 Peijia Medical Recent Developments
11.24 Zhejiang Medical Devices Co., Ltd. Owned By Year
11.24.1 Zhejiang Medical Devices Co., Ltd. Owned By Year Corporation Information
11.24.2 Zhejiang Medical Devices Co., Ltd. Owned By Year Business Overview
11.24.3 Zhejiang Medical Devices Co., Ltd. Owned By Year Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.24.4 Zhejiang Medical Devices Co., Ltd. Owned By Year Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.24.5 Zhejiang Medical Devices Co., Ltd. Owned By Year Recent Developments
11.25 Shanghai Yingtai Medical Equipment
11.25.1 Shanghai Yingtai Medical Equipment Corporation Information
11.25.2 Shanghai Yingtai Medical Equipment Business Overview
11.25.3 Shanghai Yingtai Medical Equipment Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.25.4 Shanghai Yingtai Medical Equipment Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.25.5 Shanghai Yingtai Medical Equipment Recent Developments
11.26 Beijing Taijieweiye Technology
11.26.1 Beijing Taijieweiye Technology Corporation Information
11.26.2 Beijing Taijieweiye Technology Business Overview
11.26.3 Beijing Taijieweiye Technology Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.26.4 Beijing Taijieweiye Technology Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.26.5 Beijing Taijieweiye Technology Recent Developments
11.27 Shunmei MEDICAL
11.27.1 Shunmei MEDICAL Corporation Information
11.27.2 Shunmei MEDICAL Business Overview
11.27.3 Shunmei MEDICAL Hydrophilic Neurovascular Guidewire Product Models, Descriptions and Specifications
11.27.4 Shunmei MEDICAL Hydrophilic Neurovascular Guidewire Sales, Price, Revenue and Gross Margin (2020-2025)
11.27.5 Shunmei MEDICAL Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Hydrophilic Neurovascular Guidewire Industry Chain
12.2 Hydrophilic Neurovascular Guidewire Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Hydrophilic Neurovascular Guidewire Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Hydrophilic Neurovascular Guidewire Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Hydrophilic Neurovascular Guidewire Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Hydrophilic Neurovascular Guidewire Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Hydrophilic Neurovascular Guidewire Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Hydrophilic Neurovascular Guidewire Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Hydrophilic Neurovascular Guidewire Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Hydrophilic Neurovascular Guidewire Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Hydrophilic Neurovascular Guidewire Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Hydrophilic Neurovascular Guidewire Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Hydrophilic Neurovascular Guidewire Sales by Region (2020-2025) & (K Units)
 Table 8. Global Hydrophilic Neurovascular Guidewire Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Hydrophilic Neurovascular Guidewire Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Hydrophilic Neurovascular Guidewire Sales Share by Manufacturers (2020-2025)
 Table 12. Global Hydrophilic Neurovascular Guidewire Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Hydrophilic Neurovascular Guidewire Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Hydrophilic Neurovascular Guidewire by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydrophilic Neurovascular Guidewire as of 2024)
 Table 16. Global Hydrophilic Neurovascular Guidewire Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Hydrophilic Neurovascular Guidewire Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Hydrophilic Neurovascular Guidewire Manufacturing Base and Headquarters
 Table 19. Global Hydrophilic Neurovascular Guidewire Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Hydrophilic Neurovascular Guidewire Sales by Type (2020-2025) & (K Units)
 Table 23. Global Hydrophilic Neurovascular Guidewire Sales by Type (2026-2031) & (K Units)
 Table 24. Global Hydrophilic Neurovascular Guidewire Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Hydrophilic Neurovascular Guidewire Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Hydrophilic Neurovascular Guidewire ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Hydrophilic Neurovascular Guidewire Sales by Application (2020-2025) & (K Units)
 Table 29. Global Hydrophilic Neurovascular Guidewire Sales by Application (2026-2031) & (K Units)
 Table 30. Hydrophilic Neurovascular Guidewire High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Hydrophilic Neurovascular Guidewire Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Hydrophilic Neurovascular Guidewire Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Hydrophilic Neurovascular Guidewire ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Hydrophilic Neurovascular Guidewire Growth Accelerators and Market Barriers
 Table 37. North America Hydrophilic Neurovascular Guidewire Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Hydrophilic Neurovascular Guidewire Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Hydrophilic Neurovascular Guidewire Growth Accelerators and Market Barriers
 Table 40. Europe Hydrophilic Neurovascular Guidewire Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Hydrophilic Neurovascular Guidewire Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Hydrophilic Neurovascular Guidewire Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Hydrophilic Neurovascular Guidewire Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Hydrophilic Neurovascular Guidewire Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Hydrophilic Neurovascular Guidewire Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Hydrophilic Neurovascular Guidewire Investment Opportunities and Key Challenges
 Table 47. Central and South America Hydrophilic Neurovascular Guidewire Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Hydrophilic Neurovascular Guidewire Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Hydrophilic Neurovascular Guidewire Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Terumo Medical Corporation Information
 Table 51. Terumo Medical Description and Major Businesses
 Table 52. Terumo Medical Product Models, Descriptions and Specifications
 Table 53. Terumo Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Terumo Medical Sales Value Proportion by Product in 2024
 Table 55. Terumo Medical Sales Value Proportion by Application in 2024
 Table 56. Terumo Medical Sales Value Proportion by Geographic Area in 2024
 Table 57. Terumo Medical Hydrophilic Neurovascular Guidewire SWOT Analysis
 Table 58. Terumo Medical Recent Developments
 Table 59. Medtronic Corporation Information
 Table 60. Medtronic Description and Major Businesses
 Table 61. Medtronic Product Models, Descriptions and Specifications
 Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Medtronic Sales Value Proportion by Product in 2024
 Table 64. Medtronic Sales Value Proportion by Application in 2024
 Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 66. Medtronic Hydrophilic Neurovascular Guidewire SWOT Analysis
 Table 67. Medtronic Recent Developments
 Table 68. Abbott Laboratories Corporation Information
 Table 69. Abbott Laboratories Description and Major Businesses
 Table 70. Abbott Laboratories Product Models, Descriptions and Specifications
 Table 71. Abbott Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Abbott Laboratories Sales Value Proportion by Product in 2024
 Table 73. Abbott Laboratories Sales Value Proportion by Application in 2024
 Table 74. Abbott Laboratories Sales Value Proportion by Geographic Area in 2024
 Table 75. Abbott Laboratories Hydrophilic Neurovascular Guidewire SWOT Analysis
 Table 76. Abbott Laboratories Recent Developments
 Table 77. Stryker Corporation Information
 Table 78. Stryker Description and Major Businesses
 Table 79. Stryker Product Models, Descriptions and Specifications
 Table 80. Stryker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Stryker Sales Value Proportion by Product in 2024
 Table 82. Stryker Sales Value Proportion by Application in 2024
 Table 83. Stryker Sales Value Proportion by Geographic Area in 2024
 Table 84. Stryker Hydrophilic Neurovascular Guidewire SWOT Analysis
 Table 85. Stryker Recent Developments
 Table 86. Penumbra Corporation Information
 Table 87. Penumbra Description and Major Businesses
 Table 88. Penumbra Product Models, Descriptions and Specifications
 Table 89. Penumbra Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Penumbra Sales Value Proportion by Product in 2024
 Table 91. Penumbra Sales Value Proportion by Application in 2024
 Table 92. Penumbra Sales Value Proportion by Geographic Area in 2024
 Table 93. Penumbra Hydrophilic Neurovascular Guidewire SWOT Analysis
 Table 94. Penumbra Recent Developments
 Table 95. Merit Medical Systems Corporation Information
 Table 96. Merit Medical Systems Description and Major Businesses
 Table 97. Merit Medical Systems Product Models, Descriptions and Specifications
 Table 98. Merit Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Merit Medical Systems Recent Developments
 Table 100. Boston Scientific Corporation Information
 Table 101. Boston Scientific Description and Major Businesses
 Table 102. Boston Scientific Product Models, Descriptions and Specifications
 Table 103. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Boston Scientific Recent Developments
 Table 105. Integer Holdings Corporation Corporation Information
 Table 106. Integer Holdings Corporation Description and Major Businesses
 Table 107. Integer Holdings Corporation Product Models, Descriptions and Specifications
 Table 108. Integer Holdings Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Integer Holdings Corporation Recent Developments
 Table 110. B. Braun Melsungen Corporation Information
 Table 111. B. Braun Melsungen Description and Major Businesses
 Table 112. B. Braun Melsungen Product Models, Descriptions and Specifications
 Table 113. B. Braun Melsungen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. B. Braun Melsungen Recent Developments
 Table 115. Teleflex Corporation Information
 Table 116. Teleflex Description and Major Businesses
 Table 117. Teleflex Product Models, Descriptions and Specifications
 Table 118. Teleflex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Teleflex Recent Developments
 Table 120. TE Con​​nectivity Corporation Information
 Table 121. TE Con​​nectivity Description and Major Businesses
 Table 122. TE Con​​nectivity Product Models, Descriptions and Specifications
 Table 123. TE Con​​nectivity Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. TE Con​​nectivity Recent Developments
 Table 125. Johnson & Johnson Corporation Information
 Table 126. Johnson & Johnson Description and Major Businesses
 Table 127. Johnson & Johnson Product Models, Descriptions and Specifications
 Table 128. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Johnson & Johnson Recent Developments
 Table 130. Smiths Group Corporation Information
 Table 131. Smiths Group Description and Major Businesses
 Table 132. Smiths Group Product Models, Descriptions and Specifications
 Table 133. Smiths Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Smiths Group Recent Developments
 Table 135. Asahi Intecc Corporation Information
 Table 136. Asahi Intecc Description and Major Businesses
 Table 137. Asahi Intecc Product Models, Descriptions and Specifications
 Table 138. Asahi Intecc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Asahi Intecc Recent Developments
 Table 140. Cordis Corporation Corporation Information
 Table 141. Cordis Corporation Description and Major Businesses
 Table 142. Cordis Corporation Product Models, Descriptions and Specifications
 Table 143. Cordis Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Cordis Corporation Recent Developments
 Table 145. Cook Medical Corporation Information
 Table 146. Cook Medical Description and Major Businesses
 Table 147. Cook Medical Product Models, Descriptions and Specifications
 Table 148. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. Cook Medical Recent Developments
 Table 150. Lepu Meidcal Corporation Information
 Table 151. Lepu Meidcal Description and Major Businesses
 Table 152. Lepu Meidcal Product Models, Descriptions and Specifications
 Table 153. Lepu Meidcal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. Lepu Meidcal Recent Developments
 Table 155. Scientia Vascular Corporation Information
 Table 156. Scientia Vascular Description and Major Businesses
 Table 157. Scientia Vascular Product Models, Descriptions and Specifications
 Table 158. Scientia Vascular Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 159. Scientia Vascular Recent Developments
 Table 160. FMD Co., Ltd. Corporation Information
 Table 161. FMD Co., Ltd. Description and Major Businesses
 Table 162. FMD Co., Ltd. Product Models, Descriptions and Specifications
 Table 163. FMD Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 164. FMD Co., Ltd. Recent Developments
 Table 165. Sino Medical Sciences Technology Inc. Corporation Information
 Table 166. Sino Medical Sciences Technology Inc. Description and Major Businesses
 Table 167. Sino Medical Sciences Technology Inc. Product Models, Descriptions and Specifications
 Table 168. Sino Medical Sciences Technology Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 169. Sino Medical Sciences Technology Inc. Recent Developments
 Table 170. MicroPort NeuroTech Corporation Information
 Table 171. MicroPort NeuroTech Description and Major Businesses
 Table 172. MicroPort NeuroTech Product Models, Descriptions and Specifications
 Table 173. MicroPort NeuroTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 174. MicroPort NeuroTech Recent Developments
 Table 175. Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
 Table 176. Shanghai HeartCare Medical Technology Corporation Limited Description and Major Businesses
 Table 177. Shanghai HeartCare Medical Technology Corporation Limited Product Models, Descriptions and Specifications
 Table 178. Shanghai HeartCare Medical Technology Corporation Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 179. Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
 Table 180. Peijia Medical Corporation Information
 Table 181. Peijia Medical Description and Major Businesses
 Table 182. Peijia Medical Product Models, Descriptions and Specifications
 Table 183. Peijia Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 184. Peijia Medical Recent Developments
 Table 185. Zhejiang Medical Devices Co., Ltd. Owned By Year Corporation Information
 Table 186. Zhejiang Medical Devices Co., Ltd. Owned By Year Description and Major Businesses
 Table 187. Zhejiang Medical Devices Co., Ltd. Owned By Year Product Models, Descriptions and Specifications
 Table 188. Zhejiang Medical Devices Co., Ltd. Owned By Year Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 189. Zhejiang Medical Devices Co., Ltd. Owned By Year Recent Developments
 Table 190. Shanghai Yingtai Medical Equipment Corporation Information
 Table 191. Shanghai Yingtai Medical Equipment Description and Major Businesses
 Table 192. Shanghai Yingtai Medical Equipment Product Models, Descriptions and Specifications
 Table 193. Shanghai Yingtai Medical Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 194. Shanghai Yingtai Medical Equipment Recent Developments
 Table 195. Beijing Taijieweiye Technology Corporation Information
 Table 196. Beijing Taijieweiye Technology Description and Major Businesses
 Table 197. Beijing Taijieweiye Technology Product Models, Descriptions and Specifications
 Table 198. Beijing Taijieweiye Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 199. Beijing Taijieweiye Technology Recent Developments
 Table 200. Shunmei MEDICAL Corporation Information
 Table 201. Shunmei MEDICAL Description and Major Businesses
 Table 202. Shunmei MEDICAL Product Models, Descriptions and Specifications
 Table 203. Shunmei MEDICAL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 204. Shunmei MEDICAL Recent Developments
 Table 205. Key Raw Materials Distribution
 Table 206. Raw Materials Key Suppliers
 Table 207. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 208. Milestones in Production Technology Evolution
 Table 209. Distributors List
 Table 210. Market Trends and Market Evolution
 Table 211. Market Drivers and Opportunities
 Table 212. Market Challenges, Risks, and Restraints
 Table 213. Research Programs/Design for This Report
 Table 214. Key Data Information from Secondary Sources
 Table 215. Key Data Information from Primary Sources


List of Figures
 Figure 1. Hydrophilic Neurovascular Guidewire Product Picture
 Figure 2. Global Hydrophilic Neurovascular Guidewire Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Large Product Picture
 Figure 4. Small & Medium Product Picture
 Figure 5. Global Hydrophilic Neurovascular Guidewire Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Residential
 Figure 7. Commercial
 Figure 8. Other
 Figure 9. Hydrophilic Neurovascular Guidewire Report Years Considered
 Figure 10. Global Hydrophilic Neurovascular Guidewire Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Hydrophilic Neurovascular Guidewire Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Hydrophilic Neurovascular Guidewire Revenue Market Share by Region (2020-2031)
 Figure 14. Global Hydrophilic Neurovascular Guidewire Sales (2020-2031) & (K Units)
 Figure 15. Global Hydrophilic Neurovascular Guidewire Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Hydrophilic Neurovascular Guidewire Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Hydrophilic Neurovascular Guidewire Sales Volume Market Share in 2024
 Figure 18. Global Hydrophilic Neurovascular Guidewire Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Large Revenue Market Share by Manufacturer in 2024
 Figure 21. Small & Medium Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Hydrophilic Neurovascular Guidewire Sales Market Share by Type (2020-2031)
 Figure 23. Global Hydrophilic Neurovascular Guidewire Revenue Market Share by Type (2020-2031)
 Figure 24. Global Hydrophilic Neurovascular Guidewire Sales Market Share by Application (2020-2031)
 Figure 25. Global Hydrophilic Neurovascular Guidewire Revenue Market Share by Application (2020-2031)
 Figure 26. North America Hydrophilic Neurovascular Guidewire Sales YoY (2020-2031) & (K Units)
 Figure 27. North America Hydrophilic Neurovascular Guidewire Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) in 2024
 Figure 29. North America Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Hydrophilic Neurovascular Guidewire Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe Hydrophilic Neurovascular Guidewire Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 44. France Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Hydrophilic Neurovascular Guidewire Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific Hydrophilic Neurovascular Guidewire Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 59. India Hydrophilic Neurovascular Guidewire Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Hydrophilic Neurovascular Guidewire Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America Hydrophilic Neurovascular Guidewire Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Hydrophilic Neurovascular Guidewire Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Hydrophilic Neurovascular Guidewire Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Hydrophilic Neurovascular Guidewire Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa Hydrophilic Neurovascular Guidewire Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Hydrophilic Neurovascular Guidewire Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Hydrophilic Neurovascular Guidewire Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Hydrophilic Neurovascular Guidewire Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Hydrophilic Neurovascular Guidewire Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Hydrophilic Neurovascular Guidewire Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Hydrophilic Neurovascular Guidewire Revenue (2020-2025) & (US$ Million)
 Figure 80. Hydrophilic Neurovascular Guidewire Industry Chain Mapping
 Figure 81. Regional Hydrophilic Neurovascular Guidewire Manufacturing Base Distribution (%)
 Figure 82. Global Hydrophilic Neurovascular Guidewire Production Market Share by Region (2020-2031)
 Figure 83. Hydrophilic Neurovascular Guidewire Production Process
 Figure 84. Regional Hydrophilic Neurovascular Guidewire Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart